Rafarma Pharmaceuticals is committed to building a global R&D and manufacturing network based on the principles of digitalization, Good Manufacturing Practices and Industry 4.0 concept advanced technologies.

The activities of the NOYA Pharmaceuticals group of companies cover:

• Development of presence in the markets of the product offer of our products
• Licensing and obtaining licenses for the use of patents and know-how
• Implementation of promising scientific developments
• Expansion of the range of services and products provided
• Promotion of products and services to the local market